Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | NA |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Characterization |
| Species: | Non-organism study |
| Stage: | In progress |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
Evaluating modified bNAbs to improve the breadth and potency of HIV-1 prevention
Description
CAVD 895 is a monoclonal antibody characterization study evaluating HIV bNAbs (3BNC117, 10-1074, PGDM1400, and PGT121, wild-type and variants).
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.